Lonza Group Ltd (LZAGY)
55.84
-2.45
(-4.20%)
USD |
OTCM |
May 21, 16:00
Lonza Group Cash from Operations (TTM): 1.560B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.560B |
| June 30, 2023 | 1.159B |
| December 31, 2022 | 1.059B |
| June 30, 2022 | 1.036B |
| December 31, 2021 | 1.327B |
| June 30, 2021 | 1.377B |
| December 31, 2020 | 1.221B |
| June 30, 2020 | 1.275B |
| December 31, 2019 | 993.91M |
| June 30, 2019 | 823.20M |
| December 31, 2018 | 1.091B |
| June 30, 2018 | 871.95M |
| December 31, 2017 | 852.61M |
| June 30, 2017 | 743.88M |
| December 31, 2016 | 764.33M |
| June 30, 2016 | 820.97M |
| Date | Value |
|---|---|
| December 31, 2015 | 766.29M |
| June 30, 2015 | 711.71M |
| December 31, 2014 | 515.13M |
| June 30, 2014 | 649.43M |
| December 31, 2013 | 573.25M |
| June 30, 2013 | 484.06M |
| December 31, 2012 | 760.51M |
| June 30, 2012 | 498.65M |
| December 31, 2011 | 248.53M |
| June 30, 2011 | 480.42M |
| December 31, 2010 | 494.95M |
| June 30, 2010 | 400.59M |
| December 31, 2009 | 400.25M |
| June 30, 2009 | 207.37M |
| December 31, 2008 | 162.49M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
823.20M
Minimum
Jun 2019
1.560B
Maximum
Dec 2023
1.183B
Average
1.190B
Median
Cash from Operations (TTM) Benchmarks
| Roche Holding AG | 18.04B |
| AC Immune SA | -47.96M |
| CRISPR Therapeutics AG | -159.42M |
| Addex Therapeutics Ltd | -8.901M |
| NLS Pharmaceutics Ltd | -9.684M |